BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26670253)

  • 1. Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular Junction.
    Duregotti E; Zanetti G; Scorzeto M; Megighian A; Montecucco C; Pirazzini M; Rigoni M
    Toxins (Basel); 2015 Dec; 7(12):5322-36. PubMed ID: 26670253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-latrotoxin rescues SNAP-25 from BoNT/A-mediated proteolysis in embryonic stem cell-derived neurons.
    Mesngon M; McNutt P
    Toxins (Basel); 2011 May; 3(5):489-503. PubMed ID: 22069721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of black widow spider venom on the innervation of muscles paralysed by botulinum toxin.
    Gomez S; Queiroz LS
    Q J Exp Physiol; 1982 Jul; 67(3):495-506. PubMed ID: 6287516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the action of botulinum neurotoxins A and E at cholinergic terminals.
    Washbourne P; Pellizzari R; Rossetto O; Bortoletto N; Tugnoli V; De Grandis D; Eleopra R; Montecucco C
    J Physiol Paris; 1998 Apr; 92(2):135-9. PubMed ID: 9782457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latrotoxin-Induced Neuromuscular Junction Degeneration Reveals Urocortin 2 as a Critical Contributor to Motor Axon Terminal Regeneration.
    D'Este G; Stazi M; Negro S; Megighian A; Lista F; Rossetto O; Montecucco C; Rigoni M; Pirazzini M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of temperature on the effects of the phospholipase A₂ neurotoxins β-bungarotoxin and taipoxin at the neuromuscular junction.
    Fathi B; Harvey AL; Rowan EG
    Toxicon; 2013 Aug; 70():86-9. PubMed ID: 23648422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
    Zanetti G; Sikorra S; Rummel A; Krez N; Duregotti E; Negro S; Henke T; Rossetto O; Binz T; Pirazzini M
    PLoS Pathog; 2017 Aug; 13(8):e1006567. PubMed ID: 28800600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
    Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
    Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium overload in nerve terminals of cultured neurons intoxicated by alpha-latrotoxin and snake PLA2 neurotoxins.
    Tedesco E; Rigoni M; Caccin P; Grishin E; Rossetto O; Montecucco C
    Toxicon; 2009 Aug; 54(2):138-44. PubMed ID: 19341756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targets of botulinum toxin at the mammalian neuromuscular junction.
    Whelchel DD; Brehmer TM; Brooks PM; Darragh N; Coffield JA
    Mov Disord; 2004 Mar; 19 Suppl 8():S7-S16. PubMed ID: 15027049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and purification of an irreversible presynaptic neurotoxin from the venom of the spider Hololena curta.
    Bowers CW; Phillips HS; Lee P; Jan YN; Jan LY
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3506-10. PubMed ID: 3033650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in searching for therapeutics against Botulinum Neurotoxins.
    Pirazzini M; Rossetto O
    Expert Opin Drug Discov; 2017 May; 12(5):497-510. PubMed ID: 28271909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon.
    Osborne SL; Latham CF; Wen PJ; Cavaignac S; Fanning J; Foran PG; Meunier FA
    J Neurosci Res; 2007 May; 85(6):1149-58. PubMed ID: 17387703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission.
    Meunier FA; Schiavo G; Molgó J
    J Physiol Paris; 2002; 96(1-2):105-13. PubMed ID: 11755789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins.
    Thesleff S; Molgó J; Tågerud S
    J Physiol (Paris); 1990; 84(2):167-73. PubMed ID: 2290131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-bungarotoxin-induced depletion of synaptic vesicles at the mammalian neuromuscular junction.
    Prasarnpun S; Walsh J; Harris JB
    Neuropharmacology; 2004 Aug; 47(2):304-14. PubMed ID: 15223309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protein chip membrane-capture assay for botulinum neurotoxin activity.
    Marconi S; Ferracci G; Berthomieu M; Kozaki S; Miquelis R; Boucraut J; Seagar M; Lévêque C
    Toxicol Appl Pharmacol; 2008 Dec; 233(3):439-46. PubMed ID: 18845174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Envenoming bites by kraits: the biological basis of treatment-resistant neuromuscular paralysis.
    Prasarnpun S; Walsh J; Awad SS; Harris JB
    Brain; 2005 Dec; 128(Pt 12):2987-96. PubMed ID: 16195243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
    Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
    J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.